A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19
Clinical trial NCT04953078 · COMPLETED
Trial details
- NCT number
- NCT04953078
- Sponsor
- Baiya Phytopharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-11
- Primary completion
- 2021-12-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.